Microbot Medical Inc. Announces Executive and Director Changes
Ticker: MBOT · Form: 8-K · Filed: Sep 19, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $158,115, $64,200, $32,500, $30,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation
TL;DR
Microbot Medical shakes up leadership, files on exec pay.
AI Summary
Microbot Medical Inc. announced on September 17, 2025, changes related to its board of directors and executive officers, including the departure of certain officers and the election of new directors. The company also disclosed information regarding compensatory arrangements for its officers. Specific details on the individuals involved and the financial implications of these arrangements were filed.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive and director positions can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- September 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 000-19871 (filing_id) — Commission File Number
- 94-3078125 (ein) — IRS Employer Identification No.
- 175 Derby St. , Bld. 27 Hingham , MA 02043 (address) — Address of Principal Executive Offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but specific names and details of the changes are not provided in this excerpt.
Who are the officers that have departed the company?
The filing mentions the departure of certain officers, but their names are not specified in this summary.
What is the nature of the compensatory arrangements disclosed?
The filing states that information regarding compensatory arrangements of certain officers is included, but the specifics are not detailed here.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 17, 2025.
What is the principal executive office address for Microbot Medical Inc.?
The principal executive office is located at 175 Derby St. , Bld. 27 Hingham , MA 02043.
Filing Stats: 528 words · 2 min read · ~2 pages · Grade level 13.4 · Accepted 2025-09-19 16:30:27
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Marke
- $158,115 — s CEO, President and Chairman, received $158,115; Simon Sharon, the Company's CTO, rec
- $64,200 — e Company's CTO, received approximately $64,200; and Rachel Vaknin, the Company's CEO
- $32,500 — e Company's CEO, received approximately $32,500. In making the determination to grant
- $30,000 — agement members of the Board of between $30,000 and $45,000. (d) Exhibits . Exhibit
- $45,000 — ers of the Board of between $30,000 and $45,000. (d) Exhibits . Exhibit No. Descr
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-25-014263.txt ( ) — 198KB
- mbot-20250917.xsd (EX-101.SCH) — 3KB
- mbot-20250917_lab.xml (EX-101.LAB) — 33KB
- mbot-20250917_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: September 19, 2025